வீரர்கள் வாழ்க்கைத்தொழில்கள் பெருநிறுவன தகவல்கள் கிடங்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patient-Level VHA Data Show No Association Between Paclitaxel-Coated Devices and Long-Term Mortality Created with Sketch. February 23, 2021 In the first study examining the impact of paclitaxel-coated device (PCD) use on mortality in patients treated within the Veterans Health Administration (VHA), Gutierrez et al found no increased risk of long-term all-cause mortality associated with PCD use. The study was recently published in the KEY FINDINGS The rates of 2- and 3-year all-cause mortality were similar between the PCD and non-PCD groups, even when stratified by claudication or critical limb ischemia presentations. No statistically significant risk in all-cause mortality was seen between the use of PCD and non-PCD devices after adjustment for treatment assignment.

Duke university medical centerNorth carolinaUnited statesJ antonio gutierrezVeterans health administrationCenters for medicare medicaid servicesNational death indexJournal of the american heart associationVeterans affairs corporate data warehouseAmerican heartNational deathMedicaid servicesVeteran 039s health administrationLong term mortalityMeta analysisPaclitaxel coated device